Get the Stockscreener App
0.585
33.52%
-0.295
After Hours:
.45
-0.135
-23.08%
Incannex Healthcare Inc stock is traded at $0.585, with a volume of 325.36M.
It is down -33.52% in the last 24 hours and up +171.21% over the past month.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
See More
Previous Close:
$0.88
Open:
$0.6807
24h Volume:
325.36M
Relative Volume:
2.95
Market Cap:
$106.92M
Revenue:
-
Net Income/Loss:
$-21.91M
P/E Ratio:
-0.3926
EPS:
-1.49
Net Cash Flow:
-
1W Performance:
-64.11%
1M Performance:
+171.21%
6M Performance:
-64.97%
1Y Performance:
-69.37%
1-Day Range:
$0.55
$0.7123
1-Week Range:
$0.55
$1.32
52-Week Range:
$0.08
$3.1199
Incannex Healthcare Inc Stock (IXHL) Company Profile
Name
Incannex Healthcare Inc
Sector
Phone
61 409 840 786
Address
8 CENTURY CIRCUIT, NORWEST NSW
Compare IXHL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IXHL
Incannex Healthcare Inc
|
0.585 | 82.45M | 0 | -21.91M | 0 | -1.49 |
|
ZTS
Zoetis Inc
|
145.79 | 66.25B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 42.95B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.43 | 43.30B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.45 | 19.30B | 16.54B | -1.64B | 749.00M | -1.45 |
|
NBIX
Neurocrine Biosciences Inc
|
128.23 | 13.53B | 2.41B | 305.80M | 492.20M | 2.95 |
Incannex Healthcare Inc Stock (IXHL) Latest News
Incannex has no plans, requirement to fully utilized ATM in near term - TipRanks
Incannex Healthcare shares drop 26.93% intraday after profit-taking and ATM offering expansion. - AInvest
Incannex Healthcare Highlights Strong Cash Position and Strategy - TipRanks
Incannex Confirms Strong Cash Position; No Plans or Requirement to Fully Utilise ATM in Near Term - The Manila Times
Incannex Reveals $50M Cash Strength and Breakthrough Phase 2 Results: What This Means for Shareholders - Stock Titan
3 Penny Stocks to Watch: Incannex Healthcare, XBP Europe Holdings, and AEye Inc. - AInvest
3 Penny Stocks to Watch Now, 7/29/25 - TipRanks
Top Penny Stocks To Follow NowJuly 26th - MarketBeat
Promising Penny Stocks To Add to Your WatchlistJuly 27th - MarketBeat
IXHL Shares Plunge 17.76% on Record 428.65% Volume Spike as 283rd-Busiest Stock Sparks Market Doubts Amid Promising OSA Trial Data - AInvest
Incannex drops despite mid-stage trial win for lead asset in sleep apnoea - MSN
Incannex stock drops despite trial win for lead asset (IXHL) - Seeking Alpha
Incannex Shares Climb 10% After Sleep Apnea Drug Shows Strong Phase 2 Results - MSN
What makes Incannex Healthcare Inc. stock price move sharplyWeekly Top Gainers Forecast Watchlist Released - metal.it
Nano-Cap Incannex's Sleep Apnea Candidate Shows Effectiveness And Safety In Mid-Stage Trial - Benzinga
Incannex stock soars after positive Phase 2 results for sleep apnea drug By Investing.com - Investing.com Nigeria
Incannex stock soars after positive Phase 2 results for sleep apnea drug - Investing.com Australia
Incannex reports positive Phase 2 results for OSA drug candidate By Investing.com - Investing.com Nigeria
Incannex Reports Positive Phase 2 Trial Results - TipRanks
Incannex reports positive Phase 2 results for OSA drug candidate - Investing.com
Incannex Reports Positive Topline Results from RePOSA Phase 2 Trial of IHL-42X - The Manila Times
Revolutionary Sleep Apnea Pill Achieves 83% Success Rate, First Oral Treatment for 900M Patients - Stock Titan
RSI Reset May Fuel Rebound in Incannex Healthcare Inc.Entry Alert Based on Volume Spikes Detected - metal.it
Why Incannex Healthcare Inc. stock attracts strong analyst attentionBreakout Confirmation With Entry Tracker Enabled - beatles.ru
Incannex Healthcare: European Expansion Fueling Investor Interest - timothysykes.com
Published on: 2025-07-29 13:05:19 - metal.it
3 Penny Stocks to Watch on July 29, 2025: AEye Inc., Incannex Healthcare, and SMX Public Limited - AInvest
What is the chances ixhl has good news this week and what percent 1100 - AInvest
Options Data Show Bullish Bias in Incannex Healthcare Inc.Real Time Trade Opportunity Alerts Monitor Market Surges - metal.it
What are the latest earnings results for Incannex Healthcare Inc.Low Risk Strategy With Low Risk - jammulinksnews.com
Incannex Healthcare’s Strategic Leap: Expert Joins Board - timothysykes.com
Is Incannex Healthcare Inc. stock overvalued or undervaluedExplosive capital appreciation - jammulinksnews.com
Incannex Healthcare Stock Soars 17.14% on OSA Therapy Progress - AInvest
What institutional investors are buying Incannex Healthcare Inc. stockUnlock superior stock analysis tools - jammulinksnews.com
Is Incannex Healthcare Inc. a growth stock or a value stockHigh-octane financial growth - jammulinksnews.com
Top Penny Stocks To Watch TodayJuly 25th - MarketBeat
Incannex Expands ATM Offering by $100 Million - The Globe and Mail
Incannex Healthcare's (IXHL) 64.82% Stock Surge: A Breakout in Cannabis Innovation? - AInvest
Incannex Healthcare's Breakout Momentum and the Future of Cannabis-Based Therapeutics - AInvest
Incannex Healthcare's 64.82% Stock Surge: Evaluating the Clinical Trial Catalyst as a Sustainable Growth Driver in the Evolving Cannabis-Healthcare Convergence - AInvest
Incannex Healthcare's (IXHL) 64.82% Stock Surge and the Catalyst Behind Its Cannabis Industry Breakout - AInvest
Incannex Healthcare's 33.66% Surge: Evaluating the OSA Trial Data Breakthrough - AInvest
Incannex Healthcare's OSA Trial Data and Market Implications: A High-Conviction Opportunity in Sleep Medicine Innovation - AInvest
Is Incannex Healthcare Inc. stock overhyped or has real potentialSuperior trading gains - jammulinksnews.com
Incannex Appoints Dr. Gamaldo to Advisory Board - MSN
Incannex Healthcare's Strategic ATM Expansion and OSA Trial Success: A Catalyst for Cannabis-Derived Therapeutics - AInvest
IXHL Surges: A Turning Point or Temporary Spike? - StocksToTrade
Incannex Healthcare's Strategic Capital Flexibility and OSA Trial Breakthrough: A Catalyst for Cannabis-Pharma Growth - AInvest
Incannex Healthcare stock tumbles after filing $100M offering By Investing.com - Investing.com India
Incannex Healthcare stock tumbles after filing $100M offering - Investing.com
IXHL Stock Soars: Time to Dive In? - timothysykes.com
Incannex Healthcare Inc Stock (IXHL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):